logo

Search

Login | Create Account

respiratory


Categories

Allergy Asthma COPD Cystic fibrosis End-of-life care ILD Infections Infectious diseases Interventional procedures Lung cancer Medicines Medicopolitical Podcast Public health Research Sleep

Other

Conferences

Specialties


Cardiology Dermatology Endocrinology Gastroenterology Haematology Neurology Oncology Respiratory Rheumatology

General


Contact Us About Us Website Disclaimer Privacy Policy Terms & Conditions

©2023 the limbic

logo

ALCC 2023

Wednesday 15th - Friday 17th February 2023

Australian Lung Cancer Conference 2023

Public health

Mesothelioma risk persists for some despite asbestos bans

The rate of mesothelioma diagnosis has been dropping since a peak in the early 2000s but the decrease is driven by a reduction in males who have high rates of occupational exposure. Concerningly,...

The rate of mesothelioma diagnosis has been dropping since a peak in...


Lung cancer

ALCC 23: Study identifies the best lung cancer risk prediction tool for screening

The PLCOm2012 risk prediction tool is not only more accurate than age and smoking history alone but is also more cost-effective in identifying high risk patients for access to a lung cancer screening program. Speaking at the Australian Lung Cancer Conference...

The PLCOm2012 risk prediction tool is not only more accurate than age and smoking history alone but is also more...


Lung cancer

Health professionals need to step up delivery of smoking cessation

There is an urgent need to improve the delivery of brief smoking cessation advice and interventions to patients with lung cancer. Data presented at the Australian Lung Cancer Conference showed health professionals are...

There is an urgent need to improve the delivery of brief smoking...